Biologics and Viral Analytics and Characterisation

Ensure the highest quality standards for your biologics and viral analytics with Pharmaron’s advanced characterization services. Our Liverpool-based Gene Therapy CDMO provides state-of-the-art analytical solutions to support biologics and viral vector development from early-phase research to market authorization.

Key highlights from this service overview include:

• Comprehensive Analytical Capabilities: Intact mass analysis, peptide mapping, CE-SDS, ddPCR, Cryo-EM, and next-generation sequencing (coming soon) for in-depth biologics characterization.
• Regulatory-Ready Testing: Phase-appropriate method validation, stability studies, and release testing using our AAV and recombinant protein platform analytical release kit.
• High-Throughput & Precision-Driven Approach: Automation-enabled process characterization, critical quality attribute assessment, and advanced comparability studies.

With expertise in low endotoxin recovery, forced degradation studies, and CMC dossier authoring, Pharmaron provides tailored solutions to meet evolving regulatory requirements.

Download the service overview to see how our biologics and viral analytics services can support your development pipeline.